“…[31][32][33][34][35][36] The estimated dose rate in the chest region for this technique is 26 cGy/ min, which is within the range of dose rates reported in the literature. 2,3 Although not restricted in this study, dose rate could It is important to note the irradiation of the lower limbs was not included in this paper. It is intended the legs be treated in the feet-first direction using AP/PA beams with conventional static fields.…”
Section: Resultsmentioning
confidence: 99%
“…The contouring of required PTVs and organs at risk is expected to take approximately 2 hr using the auto-contouring software MIM Maestro TM (MIM software). Total time for optimization of the nine VMAT arc is approximately 21 hr (or 3-4 working days), but requires minimal user input with automated scripting in Pinnacle 3 . This does not include the time required for planning of the legs, plan checking, and export to the record and verify system.…”
Section: Resultsmentioning
confidence: 99%
“…from 12 to 15 Gy in 6-12 fractions over 4-6 days in myeloablative approaches, with the most common prescription being 12 Gy in six fractions. [1][2][3] Low-dose TBI (2)(3)(4)(5)(6)(7)(8) Gy in 1-4 fractions) can also be used as an effective form of conditioning for older patients who may not be able to tolerate myeloablation. 1,4,5 The most significant organ toxicity associated with TBI is lung toxicity.…”
A study was undertaken to explore the use of volumetric modulated arc therapy (VMAT) for total body irradiation (TBI). Five patient plans were created in Pinnacle3 using nine 6 MV photon dynamic arcs. A dose of 12 Gy in six fractions was prescribed. The planning target volume (PTV) was split into four subsections for the head, chest, abdomen, and pelvis. The head and chest beams were optimized together, followed by the abdomen and pelvis beams. The last stage of the planning process involved turning all beams on and performing a final optimization to achieve a clinically acceptable plan. Beam isocenters were shifted by 3 or 5 mm in the left–right, anterior–posterior, and superior–inferior directions to simulate the effect of setup errors on the dose distribution. Treatment plan verification consisted of ArcCheck measurements compared to calculated doses using a global 3%/3 mm gamma analysis. All five patient plans achieved the planning aim of delivering 12 Gy to at least 90% of the target. The mean dose in the PTV was 12.7 Gy. Mean lung dose was restricted to 8 Gy, and a dose reduction of up to 40% for organs such as the liver and kidneys proved feasible. The VMAT technique was found to be sensitive to patient setup errors particularly in the superior–inferior direction. The dose predicted by the planning system agreed with measured doses and had an average pass rate of 99.2% for all arcs. VMAT was found to be a viable treatment technique for total body irradiation.
“…[31][32][33][34][35][36] The estimated dose rate in the chest region for this technique is 26 cGy/ min, which is within the range of dose rates reported in the literature. 2,3 Although not restricted in this study, dose rate could It is important to note the irradiation of the lower limbs was not included in this paper. It is intended the legs be treated in the feet-first direction using AP/PA beams with conventional static fields.…”
Section: Resultsmentioning
confidence: 99%
“…The contouring of required PTVs and organs at risk is expected to take approximately 2 hr using the auto-contouring software MIM Maestro TM (MIM software). Total time for optimization of the nine VMAT arc is approximately 21 hr (or 3-4 working days), but requires minimal user input with automated scripting in Pinnacle 3 . This does not include the time required for planning of the legs, plan checking, and export to the record and verify system.…”
Section: Resultsmentioning
confidence: 99%
“…from 12 to 15 Gy in 6-12 fractions over 4-6 days in myeloablative approaches, with the most common prescription being 12 Gy in six fractions. [1][2][3] Low-dose TBI (2)(3)(4)(5)(6)(7)(8) Gy in 1-4 fractions) can also be used as an effective form of conditioning for older patients who may not be able to tolerate myeloablation. 1,4,5 The most significant organ toxicity associated with TBI is lung toxicity.…”
A study was undertaken to explore the use of volumetric modulated arc therapy (VMAT) for total body irradiation (TBI). Five patient plans were created in Pinnacle3 using nine 6 MV photon dynamic arcs. A dose of 12 Gy in six fractions was prescribed. The planning target volume (PTV) was split into four subsections for the head, chest, abdomen, and pelvis. The head and chest beams were optimized together, followed by the abdomen and pelvis beams. The last stage of the planning process involved turning all beams on and performing a final optimization to achieve a clinically acceptable plan. Beam isocenters were shifted by 3 or 5 mm in the left–right, anterior–posterior, and superior–inferior directions to simulate the effect of setup errors on the dose distribution. Treatment plan verification consisted of ArcCheck measurements compared to calculated doses using a global 3%/3 mm gamma analysis. All five patient plans achieved the planning aim of delivering 12 Gy to at least 90% of the target. The mean dose in the PTV was 12.7 Gy. Mean lung dose was restricted to 8 Gy, and a dose reduction of up to 40% for organs such as the liver and kidneys proved feasible. The VMAT technique was found to be sensitive to patient setup errors particularly in the superior–inferior direction. The dose predicted by the planning system agreed with measured doses and had an average pass rate of 99.2% for all arcs. VMAT was found to be a viable treatment technique for total body irradiation.
“…In addition to these parameters, the patients' age, chemotherapy regimen, graft versus host disease (GVHD) prophylaxis, type of HSCT, disease, remission status, and performance status will all impact outcomes and complication incidences. Because the number of patients being treated per year at any particular institution is generally quite low, accrual for both retrospective and prospective studies is often extended and thus the studies suffer from having patient cohorts with large variability in the parameters listed as techniques change over time. This variability is difficult to account for in statistical analysis.…”
Section: Discussionmentioning
confidence: 99%
“…Total body irradiation (TBI) has a prominent role in the treatment of a variety of blood disorders requiring hematopoietic stem cell transplantation (HSCT), including cancers such as leukemia and lymphoma. [1][2][3][4][5] The use of TBI in conjunction with chemotherapy for conditioning prior to HSCT has been shown to be clinically beneficial as TBI is able to target sanctuary sites such as the brain and testes, and aids in suppressing the immune system to improve the chances of successful stem cell engraftment. 1,4,5 TBI requires the delivery of a homogeneous dose of radiation to the entire body to target all malignant blood cells as well as the bone marrow where most blood cells are formed.…”
In this work, the feasibility of using flattening filter free (FFF) beams in volumetric modulated arc therapy (VMAT) total body irradiation (TBI) treatment planning to decrease protracted beam‐on times for these treatments was investigated. In addition, a methodology was developed to generate standardized VMAT TBI treatment plans based on patient physical dimensions to eliminate plan optimization time. A planning study cohort of 47 TBI patients previously treated with optimized VMAT ARC 6 MV beams was retrospectively examined. These patients were sorted into six categories depending on height and anteroposterior (AP) width at the umbilicus. Using Varian Eclipse, clinical 40 cm × 10 cm open field arcs were substituted with 6 MV FFF. Mid‐plane lateral dose profiles in conjunction with relative arc output factors (RAOF) yielded how far a given multileaf collimator (MLC) leaf must move in order to achieve a mid‐plane 100% isodose for a specific control point. Linear interpolation gave the dynamic MLC aperture for the entire arc for each patient AP width category, which was subsequently applied through Python scripting. All FFF VMAT TBI plans were then evaluated by two radiation oncologists and deemed clinically acceptable. The FFF and clinical VMAT TBI plans had similar Body–5 mm D98% distributions, but overall the FFF plans had statistically significantly increased or broader Body–5 mm D2% and mean lung dose distributions. These differences are not considered clinically significant. Median beam‐on times for the FFF and clinical VMAT TBI plans were 11.07 and 18.06 min, respectively, and planning time for the FFF VMAT TBI plans was reduced by 34.1 min. In conclusion, use of FFF beams in VMAT TBI treatment planning resulted in dose homogeneity similar to our current VMAT TBI technique. Clinical dosimetric criteria were achieved for a majority of patients while planning and calculated beam‐on times were reduced, offering the possibility of improved patient experience.
In this work, we develop a total body irradiation technique that utilizes arc delivery, a buildup spoiler, and inverse optimized multileaf collimator (MLC) motion to shield organs at risk. The current treatment beam model is verified to confirm its applicability at extended source‐to‐surface distance (SSD). The delivery involves 7–8 volumetric modulated arc therapy arcs delivered to the patient in the supine and prone positions. The patient is positioned at a 90° couch angle on a custom bed with a 1 cm acrylic spoiler to increase surface dose. Single‐step optimization using a patient CT scan provides enhanced dose homogeneity and limits organ at risk dose. Dosimetric data of 109 TBI patients treated with this technique is presented along with the clinical workflow. Treatment planning system (TPS) verification measurements were performed at an extended SSD of 175 cm. Measurements included: a 4‐point absolute depth‐dose curve, profiles at 1.5, 5, and 10 cm depth, absolute point‐dose measurements of an treatment field, 2D Gafchromic® films at four locations, and measurements of surface dose at multiple locations of a Alderson phantom. The results of the patient DVH parameters were: Body‐5 mm D98 95.3 ± 1.5%, Body‐5 mm D2 114.0 ± 3.6%, MLD 102.8 ± 2.1%. Differences between measured and calculated absolute depth‐dose values were all <2%. Profiles at extended SSD had a maximum point difference of 1.3%. Gamma pass rates of 2D films were greater than 90% at 5%/1 mm. Surface dose measurements with film confirmed surface dose values of >90% of the prescription dose. In conclusion, the inverse optimized delivery method presented in the paper has been used to deliver homogenous dose to over 100 patients. The method provides superior patient comfort utilizing a commercial TPS. In addition, the ability to easily shield organs at risk is available through the use of MLCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.